Cargando…

Understanding gut-liver axis nitrogen metabolism in Fatty Liver Disease

The homeostasis of the most important nitrogen-containing intermediates, ammonia and glutamine, is a tightly regulated process in which the gut-liver axis plays a central role. Several studies revealed that nitrogen metabolism is altered in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Delgado, Teresa C., de las Heras, Javier, Martínez-Chantar, María L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797658/ https://www.ncbi.nlm.nih.gov/pubmed/36589817 http://dx.doi.org/10.3389/fendo.2022.1058101

Ejemplares similares

“Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease
por: Guo, Kangxiao, et al.
Publicado: (2022)

Glutamine, fatty liver disease and aging
por: Simón, Jorge, et al.
Publicado: (2021)

Chinese Medicinal Herbs Targeting the Gut–Liver Axis and Adipose Tissue–Liver Axis for Non-Alcoholic Fatty Liver Disease Treatments: The Ancient Wisdom and Modern Science
por: Zhang, Shuwei, et al.
Publicado: (2020)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

Revisiting the Role of Natural Killer Cells in Non-Alcoholic Fatty Liver Disease
por: Martínez-Chantar, María Luz, et al.
Publicado: (2021)

The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease
por: Martín-Mateos, Rosa, et al.
Publicado: (2021)

The role of TRIM family in metabolic associated fatty liver disease
por: Zhang, Jingyue, et al.
Publicado: (2023)

Metabolic Diffusion in Neuropathologies: The Relevance of Brain-Liver Axis
por: Vegas-Suárez, Sergio, et al.
Publicado: (2022)

Complex impacts of gallstone disease on metabolic syndrome and nonalcoholic fatty liver disease
por: Lyu, Jingting, et al.
Publicado: (2022)

Varied Relationship of Lipid and Lipoprotein Profiles to Liver Fat Content in Phenotypes of Metabolic Associated Fatty Liver Disease
por: Wu, Tingfeng, et al.
Publicado: (2021)

Association of Metabolic Dysfunction-Associated Fatty Liver Disease and Liver Stiffness With Bone Mineral Density in American Adults
por: Li, Hejun, et al.
Publicado: (2022)

Sequential algorithm to stratify liver fibrosis risk in overweight/obese metabolic dysfunction-associated fatty liver disease
por: Lee, Chi-Ho, et al.
Publicado: (2023)

Sphingolipids in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma: Ceramide Turnover
por: Simon, Jorge, et al.
Publicado: (2019)

Gut–Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease
por: Poeta, Marco, et al.
Publicado: (2017)

Metabolic dysfunction-associated fatty liver disease and cardiovascular disease: A meta-analysis
por: Wen, Wen, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown
por: Iacob, Simona Alexandra, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population
por: Ciardullo, Stefano, et al.
Publicado: (2021)

High-Sensitive CRP Correlates With the Severity of Liver Steatosis and Fibrosis in Obese Patients With Metabolic Dysfunction Associated Fatty Liver Disease
por: Zhu, Cuiling, et al.
Publicado: (2022)

A Bidirectional Relationship Between Hyperuricemia and Metabolic Dysfunction-Associated Fatty Liver Disease
por: Yang, Chengzhang, et al.
Publicado: (2022)

Editorial: Obesity, Smoking, and Fatty Liver Disease
por: Sinha-Hikim, Amiya P., et al.
Publicado: (2018)

Alternative RNA Splicing in Fatty Liver Disease
por: Wu, Panyisha, et al.
Publicado: (2021)

Endotoxins and Non-Alcoholic Fatty Liver Disease
por: Kessoku, Takaomi, et al.
Publicado: (2021)

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

Bile Acid Receptors and the Gut–Liver Axis in Nonalcoholic Fatty Liver Disease
por: Xue, Rui, et al.
Publicado: (2021)

Global publication trends and research hotspots of the gut-liver axis in NAFLD: A bibliometric analysis
por: Yang, Shuangjie, et al.
Publicado: (2023)

Gut Akkermansia muciniphila ameliorates metabolic dysfunction-associated fatty liver disease by regulating the metabolism of L-aspartate via gut-liver axis
por: Rao, Yong, et al.
Publicado: (2021)

Dysglycemia in young women attenuates the protective effect against fatty liver disease
por: Pérez-Montes de Oca, Alejandra, et al.
Publicado: (2022)

Cardiometabolic index: A new predictor for metabolic associated fatty liver disease in Chinese adults
por: Duan, Shaojie, et al.
Publicado: (2022)

Clinical features and metabolic complications for non-alcoholic fatty liver disease (NAFLD) in youth with obesity
por: Barbieri, Emiliano, et al.
Publicado: (2023)

Impaired ketogenesis is associated with metabolic-associated fatty liver disease in subjects with type 2 diabetes
por: Lee, Sejeong, et al.
Publicado: (2023)

The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease
por: Hu, Yingying, et al.
Publicado: (2023)

The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancer
por: Wei, Suosu, et al.
Publicado: (2023)

Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China
por: Lei, Fang, et al.
Publicado: (2023)

Prevalence and associated factors of metabolic-associated fatty liver disease in overweight Finnish children and adolescents
por: Riekki, Hanna, et al.
Publicado: (2023)

Editorial: Metabolic associated fatty liver disease: clinical perspectives from pathogenesis to diagnosis and treatment
por: Huang, Zhe, et al.
Publicado: (2023)

Editorial: Interaction of endocrine disorders and metabolic associated fatty liver disease: the genetic and epigenetic basis
por: Pan, Qin, et al.
Publicado: (2023)

Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids
por: Ni, Yiming, et al.
Publicado: (2023)

Role of extracellular vesicles in nonalcoholic fatty liver disease
por: Jiang, Wei, et al.
Publicado: (2023)

Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
por: Cuthbertson, Daniel J., et al.
Publicado: (2021)

IRX3 plays an important role in the pathogenesis of metabolic-associated fatty liver disease by regulating hepatic lipid metabolism
por: Ma, Yongqiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q2chavfhcvuji9msk8no5bjpld